We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

JPML Eyes Gadolinium Contrast Agent Cases

Law360 (October 25, 2007, 12:00 AM EDT) -- As product liability suits against makers of injectable contrast agents that allegedly cause serious health problems in patients with kidney problems continue to pile up, the U.S. Judicial Panel on Multidistrict Litigation is considering consolidation.

A representative for the MDL panel confirmed Thursday that it had received a motion to transfer cases involving product liability claims against the makers of gadolinium-based contrast agents used in MRI testing. The panel has started the process that may lead to the docketing of the MDL case.

Suits against contrast...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.